Trials / Completed
CompletedNCT02066844
Navigator vs Standard Needle Injection for Hip
Phase II Study of Navigator vs Standard Needle Injection for Hip
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Cartiva, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this randomized, parallel-group, single-blinded, single center, Phase II study is to collect data to compare the comfort and patient satisfaction of a hip injection delivered via the Navigator compared to a standard needle injection. In addition, delivery preparation will be compared between a Navigator injection and a standard hip injection. The data collected from this pilot study will serve as the basis to design a larger multi-center study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Celestone | 2cc |
| DRUG | Lidocaine | 5cc |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2014-02-20
- Last updated
- 2016-01-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02066844. Inclusion in this directory is not an endorsement.